HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does endothelin play a role in chemoreception during acute hypoxia in normal men?

AbstractBACKGROUND:
The peripheral chemoreceptors are the dominant reflex mechanism responsible for the rise in ventilation and muscle sympathetic nerve activity (MSNA) in response to hypoxia. Animal studies have suggested that endothelin (ET) plays an important role in chemosensitivity. Moreover, several human clinical conditions in which circulating ET levels are increased are accompanied by enhanced chemoreflex sensitivity. Whether ET plays a role in normal human chemosensitivity is unknown.
METHODS:
We determined whether bosentan, a nonspecific ET receptor antagonist, would decrease chemoreflex sensitivity in 14 healthy subjects. We assessed the effects of bosentan on the response to isocapnic hypoxia, using a randomized, crossover, double-blinded study design.
RESULTS:
Bosentan increased mean (+/- SEM) plasma ET levels from 1.97 +/- 0.28 to 2.53 +/- 0.23 pg/mL (p = 0.01). Hypoxia increased mean minute ventilation from 6.7 +/- 0.3 to 8+/0.4 L/min (p < 0.01), mean MSNA from 100 to 111 +/- 5% (p < 0.01), mean heart rate from 67 +/- 3 to 86 +/- 3 beats/min (p < 0.01), and mean systolic BP from 116 +/- 3 to 122 +/- 3 mm Hg (p < 0.01). However, none of these responses differed between therapy with bosentan and therapy with placebo (p = 0.26). Bosentan did not affect the mean MSNA responses to the apneas, during normoxia (change from baseline: placebo, 259 +/- 58%; bosentan, 201 +/- 28%; p = 0.17) or during hypoxia (change from baseline: placebo, 469 +/- 139%; bosentan, 329 +/- 46%; p = 0.24). The durations of the voluntary end-expiratory apneas in normoxia and hypoxia, and the subsequent reductions in oxygen saturation, were also similar with therapy using bosentan and placebo (p = 0.42).
CONCLUSION:
In healthy men, ET does not play an important role in peripheral chemoreceptor activation by acute hypoxia.
AuthorsMarko Gujic, Anne Houssière, Olivier Xhaët, Jean-François Argacha, Nathalie Denewet, André Noseda, Pascale Jespers, Christian Melot, Robert Naeije, Philippe van de Borne
JournalChest (Chest) Vol. 131 Issue 5 Pg. 1467-72 (May 2007) ISSN: 0012-3692 [Print] United States
PMID17494795 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelin Receptor Antagonists
  • Endothelins
  • Receptors, Endothelin
  • Sulfonamides
  • Bosentan
Topics
  • Acute Disease
  • Adult
  • Apnea (physiopathology)
  • Blood Pressure (drug effects, physiology)
  • Bosentan
  • Chemoreceptor Cells (physiology)
  • Cross-Over Studies
  • Double-Blind Method
  • Endothelin Receptor Antagonists
  • Endothelins (physiology)
  • Heart Rate (drug effects, physiology)
  • Humans
  • Hypoxia (physiopathology)
  • Male
  • Muscles (innervation)
  • Pulmonary Ventilation (drug effects, physiology)
  • Receptors, Endothelin (physiology)
  • Sulfonamides (pharmacology)
  • Sympathetic Nervous System (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: